title: Fatal pneumocystis jiroveci pneumonia in ABVD-treated Hodgkin lymphoma patients.
authors.forename: Mats
authors.initials: M
authors.lastname: Kalin
authors.forename: Sigurdur Yngvi
authors.initials: SY
authors.lastname: Kristinsson
authors.forename: Honar
authors.initials: H
authors.lastname: Cherif
authors.forename: Marianne
authors.initials: M
authors.lastname: Lebbad
authors.forename: Magnus
authors.initials: M
authors.lastname: Björkholm
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001761:Bleomycin / Q000009:adverse effects; D003606:Dacarbazine / Q000009:adverse effects; D004317:Doxorubicin / Q000009:adverse effects; D005260:Female; D006689:Hodgkin Disease / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D045363:Pneumocystis carinii; D011020:Pneumonia, Pneumocystis / Q000139:chemically induced / Q000209:etiology / Q000401:mortality*; D012189:Retrospective Studies; D014747:Vinblastine / Q000009:adverse effects; D055815:Young Adult
chemical_list: D001761:Bleomycin; D014747:Vinblastine; D003606:Dacarbazine; D004317:Doxorubicin